Activation of SOCS-3 by Resistin

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2005 Feb 3

PMID 15684405

Citations 80

Authors

Claire M Steppan

Juan Wang

Eileen L Whiteman

Morris J Birnbaum

Mitchell A Lazar

Affiliations

Soon will be listed here.

Abstract

Resistin is an adipocyte hormone that modulates glucose homeostasis. Here we show that in 3T3-L1 adipocytes, resistin attenuates multiple effects of insulin, including insulin receptor (IR) phosphorylation, IR substrate 1 (IRS-1) phosphorylation, phosphatidylinositol-3-kinase (PI3K) activation, phosphatidylinositol triphosphate production, and activation of protein kinase B/Akt. Remarkably, resistin treatment markedly induces the gene expression of suppressor of cytokine signaling 3 (SOCS-3), a known inhibitor of insulin signaling. The 50% effective dose for resistin induction of SOCS-3 is approximately 20 ng/ml, close to levels of resistin in serum. Association of SOCS-3 protein with the IR is also increased by resistin. Inhibition of SOCS function prevented resistin from antagonizing insulin action in adipocytes. SOCS-3 induction is the first cellular effect of resistin that is independent of insulin and is a likely mediator of resistin's inhibitory effect on insulin signaling in adipocytes.

Citing Articles

Changes in Cells Associated with Insulin Resistance.

Szablewski L Int J Mol Sci. 2024; 25(4).

PMID: 38397072 PMC: 10889819. DOI: 10.3390/ijms25042397.

The Role of Adipokines in the Control of Pituitary Functions.

Kaminska B, Kurowicka B, Kiezun M, Dobrzyn K, Kisielewska K, Gudelska M Animals (Basel). 2024; 14(2).

PMID: 38275812 PMC: 10812442. DOI: 10.3390/ani14020353.

Adipokines and Bacterial Metabolites: A Pivotal Molecular Bridge Linking Obesity and Gut Microbiota Dysbiosis to Target.

Turpin T, Thouvenot K, Gonthier M Biomolecules. 2023; 13(12).

PMID: 38136564 PMC: 10742113. DOI: 10.3390/biom13121692.

Insulin signaling and its application.

Le T, Dao X, Nguyen D, Luu D, Bui T, Le T Front Endocrinol (Lausanne). 2023; 14:1226655.

PMID: 37664840 PMC: 10469844. DOI: 10.3389/fendo.2023.1226655.

Resistin stimulates PC-3 prostate cancer cell growth through stimulation of SOCS3 and SOCS5 genes.

Liu C, Peng H, Siao A, Tsuei Y, Lin Y, Shiah S Exp Biol Med (Maywood). 2023; 248(20):1695-1707.

PMID: 37646261 PMC: 10792425. DOI: 10.1177/15353702231191206.

References

Krebs D, Hilton D . A new role for SOCS in insulin action. Suppressor of cytokine signaling. Sci STKE. 2003; 2003(169):PE6. DOI: 10.1126/stke.2003.169.pe6. View

Rajala M, Obici S, Scherer P, Rossetti L . Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest. 2003; 111(2):225-30. PMC: 151868. DOI: 10.1172/JCI16521. View

Moon B, Kwan J, Duddy N, Sweeney G, Begum N . Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am J Physiol Endocrinol Metab. 2003; 285(1):E106-15. DOI: 10.1152/ajpendo.00457.2002. View

Gual P, Gonzalez T, Gremeaux T, Barres R, Le Marchand-Brustel Y, Tanti J . Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes. J Biol Chem. 2003; 278(29):26550-7. DOI: 10.1074/jbc.M212273200. View

Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A . Correlation between serum resistin level and adiposity in obese individuals. Obes Res. 2003; 11(8):997-1001. DOI: 10.1038/oby.2003.137. View

Whiteman E, Chen J, Birnbaum M . Platelet-derived growth factor (PDGF) stimulates glucose transport in 3T3-L1 adipocytes overexpressing PDGF receptor by a pathway independent of insulin receptor substrates. Endocrinology. 2003; 144(9):3811-20. DOI: 10.1210/en.2003-0480. View

Zhang J, Qin Y, Zheng X, Qiu J, Zou D . Serum resistin level in essential hypertension patients with different glucose tolerance. Diabet Med. 2003; 20(10):828-31. DOI: 10.1046/j.1464-5491.2003.01057.x. View

Degawa-Yamauchi M, Bovenkerk J, Juliar B, Watson W, Kerr K, Jones R . Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab. 2003; 88(11):5452-5. DOI: 10.1210/jc.2002-021808. View

Pirola L, Johnston A, Van Obberghen E . Modulators of insulin action and their role in insulin resistance. Int J Obes Relat Metab Disord. 2004; 27 Suppl 3:S61-4. DOI: 10.1038/sj.ijo.0802504. View

10.

Youn B, Yu K, Park H, Lee N, Min S, Youn M . Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2004; 89(1):150-6. DOI: 10.1210/jc.2003-031121. View

11.

Banerjee R, Rangwala S, Shapiro J, Rich A, Rhoades B, Qi Y . Regulation of fasted blood glucose by resistin. Science. 2004; 303(5661):1195-8. DOI: 10.1126/science.1092341. View

12.

Silha J, Murphy L . Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab. 2004; 89(4):1977. DOI: 10.1210/jc.2003-031988. View

13.

Kim K, Zhao L, Moon Y, Kang C, Sul H . Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc Natl Acad Sci U S A. 2004; 101(17):6780-5. PMC: 404122. DOI: 10.1073/pnas.0305905101. View

14.

Ueki K, Kondo T, Kahn C . Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol. 2004; 24(12):5434-46. PMC: 419873. DOI: 10.1128/MCB.24.12.5434-5446.2004. View

15.

Rajala M, Qi Y, Patel H, Takahashi N, Banerjee R, Pajvani U . Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes. 2004; 53(7):1671-9. DOI: 10.2337/diabetes.53.7.1671. View

16.

Shi H, Tzameli I, Bjorbaek C, Flier J . Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem. 2004; 279(33):34733-40. DOI: 10.1074/jbc.M403886200. View

17.

Roden M, Price T, Perseghin G, Petersen K, Rothman D, Cline G . Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996; 97(12):2859-65. PMC: 507380. DOI: 10.1172/JCI118742. View

18.

Bjorbaek C, Elmquist J, Frantz J, Shoelson S, Flier J . Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell. 1998; 1(4):619-25. DOI: 10.1016/s1097-2765(00)80062-3. View

19.

Staubs P, Nelson J, Reichart D, Olefsky J . Platelet-derived growth factor inhibits insulin stimulation of insulin receptor substrate-1-associated phosphatidylinositol 3-kinase in 3T3-L1 adipocytes without affecting glucose transport. J Biol Chem. 1998; 273(39):25139-47. DOI: 10.1074/jbc.273.39.25139. View

20.

Bjorbaek C, El-Haschimi K, Frantz J, Flier J . The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem. 1999; 274(42):30059-65. DOI: 10.1074/jbc.274.42.30059. View